vaginal atrophy

Known as: vagina atrophy 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
OBJECTIVE The aim of this work was to study the role of ospemifene, a novel selective estrogen receptor modulator, in the… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Unlike hot flushes and night sweats which resolve spontaneously in time, atrophic symptoms affecting the vagina and lower urinary… (More)
  • figure 1
  • figure 2
Is this relevant?
2010
2010
The study aim is to evaluate the efficacy and safety of two low-dose vaginal estrogen treatments (ETs) and of a non-hormonal… (More)
  • table I
  • table III
Is this relevant?
Highly Cited
2009
Highly Cited
2009
OBJECTIVE Because the secretion of dehydroepiandrosterone (DHEA), the exclusive source of sex steroids in postmenopausal women… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVE To evaluate the efficacy of ultra-low-dose 10-microgram 17beta-estradiol (E2) vaginal tablets for treatment of vaginal… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2000
2000
BACKGROUND Atrophic vaginitis is a common condition. This study compared the usefulness of estradiol vaginal tablets (EVT) and… (More)
Is this relevant?
1997
1997
OBJECTIVES To determine if the efficacy of continuous low dose estradiol released from a vaginal ring is equivalent to estriol… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
OBJECTIVES This study was designed to evaluate the efficacy of Replens, a non-hormonal moisturizing vaginal gel, on symptoms of… (More)
Is this relevant?
Highly Cited
1983
Highly Cited
1983
The effect of sexual activity on vaginal atrophy was investigated in a group of 52 postmenopausal women (mean age, 57 years… (More)
Is this relevant?